Showing 1 - 10 of 27
Persistent link: https://www.econbiz.de/10006735184
Persistent link: https://www.econbiz.de/10005466233
To test the effect of differences in acquisition cost and budget-based monetary compensation systems on the intent to support the adoption of a cost-effective new drug, over 350 hospital pharmacy directors were asked to indicate their intentions as to the adoption of a cost-effective new...
Persistent link: https://www.econbiz.de/10005007612
Little is known about factors that affect pharmacists' roles in off-label prescribing. This study examined the effect of perceived impact on relationship quality (IRQ) on hospital pharmacists' willingness to influence a physician's decision regarding an indication-based off-label medication...
Persistent link: https://www.econbiz.de/10011263510
Persistent link: https://www.econbiz.de/10004130851
Persistent link: https://www.econbiz.de/10004694518
Persistent link: https://www.econbiz.de/10004694543
Persistent link: https://www.econbiz.de/10013182698
BackgroundThe Orphan Drug Act (1983) established several incentives to encourage the development of orphan drugs (ODs) to treat rare diseases and conditions. This study analyzed the characteristics of OD designations, approvals, sponsors, and evaluated the effective patent and market exclusivity...
Persistent link: https://www.econbiz.de/10009475147
Persistent link: https://www.econbiz.de/10006627830